Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can These 2 Stocks Crush the Market Again in 2023?

TheMotleyFool

0 0

Can These 2 Stocks Crush the Market Again in 2023?: https://g.foolcdn.com/editorial/images/711240/physician-giving-medicine-to-elderly-patient.jpg

Equities have been southbound for most of the year. And after a solid performance in the early days of the pandemic, the biotech industry is lagging the struggling overall stock market.

But some biotechs are doing great. The list includes Regeneron Pharmaceuticals (NASDAQ: REGN) and Biogen (NASDAQ: BIIB). These two drugmakers are comfortably in the green year to date and could carry this momentum into 2023. But will they repeat this performance next year?